Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device.

OBJECTIVE We sought to investigate differences in indices of pulsatility between patients with normal ventricular function and patients with heart failure studied at the time of implantation with continuous-flow or pulsatile-flow left ventricular assist devices. METHODS Eight patients with normal ventricular function and 22 patients with heart failure were studied. A high-fidelity aortic and left ventricular pressure catheter was inserted retrograde through the aortic valve into the left ventricle, and transit-time flow probes were placed on the aorta and device outflow graft. Hemodynamic waveforms were recorded at native heart rate before cardiopulmonary bypass and over a range of device flow rates controlled by adjusting beat rate or rpm. These data were used to calculate vascular input impedance and 2 indices of vascular pulsatility: energy-equivalent pressure and surplus hemodynamic energy. RESULTS At low support levels, pulsatile support restored surplus hemodynamic energy to within 2.5% of normal values, whereas continuous support diminished surplus energy by more than 93%. At high support levels, pulsatile support augmented surplus energy by 49% over normal values, whereas continuous support further diminished surplus energy by 97%. Pulsatile support diminished vascular impedance from baseline failure values, whereas continuous support increased impedance. Vascular impedances at baseline for patients undergoing pulsatile and continuous support and during pulsatile support revealed normal vascular compliance, whereas impedance during continuous support indicated a loss of compliance (or "stiffening") of the vasculature. CONCLUSION These results suggest that selection of device type and flow rate can influence vascular pulsatility and input impedance, which might affect clinical outcomes.

[1]  Steven C Koenig,et al.  Integrated data acquisition system for medical device testing and physiology research in compliance with good laboratory practices. , 2004, Biomedical instrumentation & technology.

[2]  Y. Nosé Nonpulsatile mode of blood flow required for cardiopulmonary bypass and total body perfusion. , 2008, Artificial organs.

[3]  John L. Myers,et al.  Precise Quantification of Pressure Flow Waveforms of a Pulsatile Ventricular Assist Device , 2005, ASAIO journal.

[4]  A Undar,et al.  Defining pulsatile perfusion: quantification in terms of energy equivalent pressure. , 1999, Artificial organs.

[5]  S. Houser,et al.  Regression of cellular hypertrophy after left ventricular assist device support. , 1998, Circulation.

[6]  J. Kirklin,et al.  Advances in Heart Failure Mechanical Circulatory Support Registering a Therapy in Evolution , 2008 .

[7]  O. Frazier,et al.  Mechanical Circulatory Support for Advanced Heart Failure: Where Does It Stand in 2003? , 2003, Circulation.

[8]  G Wright,et al.  Hemodynamic analysis could resolve the pulsatile blood flow controversy. , 1994, The Annals of thoracic surgery.

[9]  Robert L Kormos,et al.  Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  J. Linneweber,et al.  Analysis of the arterial blood pressure waveform using Fast Fourier Transform technique during left ventricular nonpulsatile assistance: in vitro study. , 2000, Artificial organs.

[11]  G P Noon,et al.  Pulsatile Flow in Patients With a Novel Nonpulsatile Implantable Ventricular Assist Device , 2000, Circulation.

[12]  A. Ündar,et al.  Energy Equivalent Pressure and Total Hemodynamic Energy Associated with the Pressure-Flow Waveforms of a Pediatric Pulsatile Ventricular Assist Device , 2005, ASAIO journal.

[13]  J. Linneweber,et al.  Analysis of the arterial blood pressure waveform during left ventricular nonpulsatile assistance in animal models. , 2000, Artificial organs.

[14]  G. Noon,et al.  Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. , 1999, Circulation.

[15]  N. Smedira,et al.  Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart , 2001, Circulation.

[16]  A Undar,et al.  Pulsatile and nonpulsatile flows can be quantified in terms of energy equivalent pressure during cardiopulmonary bypass for direct comparisons. , 1999, ASAIO journal.

[17]  S. Houser,et al.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. , 1998, Circulation.

[18]  R B Shepard,et al.  Energy equivalent pressure. , 1966, Archives of surgery.

[19]  D. Burkhoff,et al.  Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure , 2000, Circulation.

[20]  Daniel L. Ewert,et al.  HEART: an automated beat-to-beat cardiovascular analysis package using Matlab® , 2004, Comput. Biol. Medicine.

[21]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[22]  John P. Gaughan,et al.  Electrophysiological Alterations After Mechanical Circulatory Support in Patients With Advanced Cardiac Failure , 2001, Circulation.

[23]  M C Oz,et al.  Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. , 1995, Circulation.

[24]  G. Noon,et al.  Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  A. Undar,et al.  Comparison of six pediatric cardiopulmonary bypass pumps during pulsatile and nonpulsatile perfusion. , 2001, The Journal of thoracic and cardiovascular surgery.

[26]  M. Loebe,et al.  Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  Akif Ündar,et al.  Myths and truths of pulsatile and nonpulsatile perfusion during acute and chronic cardiac support. , 2004 .

[28]  Eric Rosow,et al.  Virtual Bio-Instrumentation: Biomedical, Clinical, and Healthcare Applications in LabVIEW , 2001 .